David J. Maron

Stanford University
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Background: Coronary artery calcium (CAC) can be identified on nongated chest computed tomography (CT) scans, but this finding is not consistently incorporated into care. A deep learning algorithm enables opportunistic CAC screening of nongated chest CT scans. Our objective was to evaluate the effect of notifying clinicians and patients of incidental CAC on statin initiation. Methods: NOTIFY-1 (Incidental Coronary Calcification Quality Improvement Project) was a randomized quality improvement project in the Stanford Health Care System. Patients without known atherosclerotic cardiovascular disease or a previous statin prescription were screened for CAC on a previous nongated chest CT scan from 2014 to 2019 using a validated deep learning algorithm with radiologist confirmation. Patients with incidental CAC were randomly assigned to notification of the primary care clinician and patient versus usual care. Notification included a patient-specific image of CAC and guideline recommendations regarding statin use. The primary outcome was statin prescription within 6 months. Results: Among 2113 patients who met initial clinical inclusion criteria, CAC was identified by the algorithm in 424 patients. After chart review and additional exclusions were made, a radiologist confirmed CAC among 173 of 194 patients (89.2%) who were randomly assigned to notification or usual care. At 6 months, the statin prescription rate was 51.2% (44/86) in the notification arm versus 6.9% (6/87) with usual care ( P <0.001). There was also more coronary artery disease testing in the notification arm (15.1% [13/86] versus 2.3% [2/87]; P =0.008). Conclusions: Opportunistic CAC screening of previous nongated chest CT scans followed by clinician and patient notification led to a significant increase in statin prescriptions. Further research is needed to determine whether this approach can reduce atherosclerotic cardiovascular disease events. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04789278.

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (12)

Nicholas Cauwenberghs

-

BELGIUM
View details

Tomasz Mazurek

associate professor

Medical University of Warsaw

POLAND
View details

Summer Ngo

Stanford University School of Medicine

UNITED STATES
View details

Stacy Farr

Johns Hopkins University

UNITED STATES
View details

Judith Hochman

Harold Snyder Family Professor of Cardiology (Academic)

NYU School of Medicine

UNITED STATES
View details

Marek Roik

Medical University of Warsaw

POLAND
View details

Frank Rockhold

Professor

Duke University School of Medicine

UNITED STATES
View details

Tina Hernandez-Boussard

Associate Dean of Research | Professor of Medicine | C-Suite & NIH Advisor | Board Director | Corporate Governance & Digital Health Strategy

Stanford University

UNITED STATES
View details

Tatiana Kuznetsova

Head of Research Unit Hypertension and CV Epidemiology/ Associate Professor

KU Leuven

BELGIUM
View details

Dominik Fleischmann

Chief of Cardiovascular Imaging

Stanford University

UNITED STATES
View details

Philip Greenland

Professor

Northwestern University

UNITED STATES
View details

Ruth Masterson Creber

Professor of Nursing

Columbia University

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.